• admin@ataxiatelangiectasia.es
Ataxia Telangiectasia
  • Home
  • Was ist A-T?
  • Nachricht
  • Ataxia-telangiectasia: Immunodeficiency and survival.
  • Ataxia-telangiectasia: recommendations for multidisciplinary treatment.
  • Genotype-phenotype correlations in ataxia telangiectasia patients with ATM c.3576G>A and c.8147T>C mutations.
  • Health risks for ataxia-telangiectasia mutated heterozygotes: a systematic review, meta-analysis and evidence-based guideline.
  • Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours.
  • Nicotinamide Riboside Improves Ataxia Scores and Immunoglobulin Levels in Ataxia Telangiectasia
  • Telangiectasias in Ataxia Telangiectasia: Clinical significance, role of ATM deficiency and potential pathophysiological mechanisms.
  • Trajectories of motor abnormalities in milder phenotypes of ataxia telangiectasia.

Language

  Deutsch (Deutschland)
  • Hindi (India)
  • Hebrew
  • Arabic (اللغة العربية)
  • Turkish (Turkey)
  • 日本語 (Japan)
  • Russian (Russia)
  • Français (France)
  • Deutsch (Deutschland)
  • Español (España)
  • Nederlands (nl-NL)
  • Português Brasileiro (pt-BR)
  • Polski (PL)
  • Italiano (Italia)
  • English (United Kingdom)

Tweets by A_Tinfo

Ataxia Telangiectasia
  • Home
  • Was ist A-T?
  • Nachricht
  • admin@ataxiatelangiectasia.es